Chicago Partners Investment Group LLC Purchases 1,285 Shares of UnitedHealth Group Incorporated $UNH

Chicago Partners Investment Group LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,698 shares of the healthcare conglomerate’s stock after buying an additional 1,285 shares during the period. Chicago Partners Investment Group LLC’s holdings in UnitedHealth Group were worth $3,636,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Richardson Financial Services Inc. increased its position in UnitedHealth Group by 10.9% during the 3rd quarter. Richardson Financial Services Inc. now owns 774 shares of the healthcare conglomerate’s stock valued at $284,000 after purchasing an additional 76 shares during the period. Signet Investment Advisory Group Inc. boosted its stake in shares of UnitedHealth Group by 2.9% during the 3rd quarter. Signet Investment Advisory Group Inc. now owns 10,204 shares of the healthcare conglomerate’s stock valued at $3,746,000 after purchasing an additional 290 shares in the last quarter. 3Chopt Investment Partners LLC increased its position in shares of UnitedHealth Group by 11.3% during the third quarter. 3Chopt Investment Partners LLC now owns 3,766 shares of the healthcare conglomerate’s stock valued at $1,383,000 after buying an additional 382 shares during the period. Team Financial Group LLC bought a new position in UnitedHealth Group in the third quarter worth about $129,000. Finally, Focused Wealth Management Inc lifted its holdings in UnitedHealth Group by 6.3% in the third quarter. Focused Wealth Management Inc now owns 9,185 shares of the healthcare conglomerate’s stock worth $3,372,000 after buying an additional 545 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on UNH shares. Barclays dropped their price target on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 14th. Piper Sandler boosted their target price on shares of UnitedHealth Group from $502.00 to $504.00 and gave the company an “overweight” rating in a report on Wednesday, October 14th. Sanford C. Bernstein reduced their target price on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 14th. Erste Group Bank cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, August 27th. Finally, DA Davidson set a $512.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Twenty investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $463.93.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $395.74 on Friday. The business has a fifty day moving average price of $390.63 and a 200-day moving average price of $363.75. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The company has a market capitalization of $354.59 billion, a PE ratio of 22.60, a PEG ratio of 1.48 and a beta of 0.51. UnitedHealth Group Incorporated has a 1-year low of $255.96 and a 1-year high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.72 billion for the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the business posted $2.59 EPS. UnitedHealth Group’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Stockholders of record on Monday, December 7th will be issued a dividend of $2.32 per share. The ex-dividend date is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is owned by company insiders.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported quarterly adjusted earnings of $4.69 per share, above the $4.14 consensus estimate, and revenue also topped expectations. The results have been described as evidence of a possible margin recovery, while the company maintained its fiscal 2026 earnings guidance. UnitedHealth Q3 earnings and margin recovery
• Positive Sentiment: The board declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a 2.3% yield. The payment is scheduled for December 15 to shareholders of record December 7. UnitedHealth quarterly dividend announcement
• Neutral Sentiment: Some recent coverage characterizes UNH as a long-term momentum stock, but the available article details do not provide a new company-specific catalyst. UnitedHealth as a long-term momentum stock
• Negative Sentiment: Baron Capital cited utilization and policy concerns weighing on UnitedHealth in its healthcare fund commentary. Such concerns can raise uncertainty about medical costs and the regulatory environment. Utilization and policy concerns
• Negative Sentiment: Renewed calls from Senator Elizabeth Warren for antitrust scrutiny, along with warnings that AI could disrupt large healthcare companies, add regulatory and competitive risks to the outlook. Breakup pressure and AI threat

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.